A retrospective analysis of HRG mRNA levels, as assessed by reverse transcriptase–quantitative PCR in tumor tissue, showed that patients with HRG mRNA levels above the median progressed more rapidly on the control arm than patients with levels below the median. The gene discussed is HRG; the disease is neoplasm.